摘要
T细胞非霍奇金淋巴瘤是一组具有独特临床和病理特征的疾病，与B细胞淋巴瘤相比，侵袭性更强，化疗敏感性差。为探索有效的治疗方案，近年来，新的药物如吉西他滨、靶向药物联合化疗及高剂量化疗联合造血干细胞移植被研究用于治疗T细胞淋巴瘤，并取得了一些进展。
T-cell non-Hodgkin lymphoma is a group disease with unique clinical and pathological features. It is more aggressive and has lower chemotherapy sensitivity than B-cell lymphoma. In recent years, to search for effective treatment, novel agents such as gemcitahine, targeted therapy combined with chemotherapy and high-dose chemotherapy combined with hemotopoietic stem cell transplantation are applied in the treatment of T-cell non-Holt, kin lymphoma. And some progresses are achieved.
出处
《国际肿瘤学杂志》
CAS
2011年第8期626-629,共4页
Journal of International Oncology
